IL-1 is also an important mediator of autoimmune diseases as evidenced by the therapeutic efficacy of IL-1Ra or IL-1β specific antibodies for treatment of rheumatoid arthritis [159] and gouty arthritis [165]. This evidence concerns the gene IL1B and gout.